Oncology Times Broadcast NewsSwedish Registry Study Shows Hormone Therapy for Prostate Cancer Increased All Cardiovascular MortalityMieke Van Hemelrijck at ECCO15-ESMO34 on findings that cardiovascular mortality from heart failure and arrhy

Aromatase Inhibitor Better Than Tamoxifen For Initial Adjuvant Therapy For Hormone Receptor Positive Breast Cancer, But Compliance An Issue!

Oct 6th, 2009 6m 57s

Oncology Times Broadcast NewsAromatase Inhibitor Better than Tamoxifen for Initial Adjuvant Therapy for HR- Positive Breast Cancer, But Compliance an Issue!Cornelis van de Velde at ECCO15-ESMO34 on the largest comparison of an aromatase inh

Longer Follow-up Reveals: Aspirin Prevents Cancer in Lynch Syndrome

Sep 28th, 2009 7m 19s

John Burn talking at ECCO15-ESMO34 in Berlin about his international study showing that aspirin prevented the development of Hereditary Non-Polyposis Colon Cancer in people genetically at risk for the disease.

For Early Breast Cancer, Switch to Aromatase Inhibitor after Tamoxifen Extends Survival

Sep 28th, 2009 6m 3s

Oncology Times Broadcast NewsFor Early Breast Cancer, Switch to Aromatase Inhibitor after Tamoxifen Extends SurvivalCharles Coombes at ECCO15-ESMO34 on the Intergroup Exemestane Study showing a big increase in survival for patients with ear

Bevacizumab Did Not Improve Disease-Free Survival In Adjuvant Therapy For Early Colon Cancer

Sep 28th, 2009 9m 5s

Oncology Times Broadcast News: Bevacizumab Did Not Improve Disease-Free Survival In Adjuvant Therapy For Early Colon Cancer For adjuvant treatment of stage II and stage III colorectal cancer the vascular endothelial growth factor (VEGF) r

"Promising Activity" Of Cetuximab In Patients With Advanced Biliary Cancer

Sep 28th, 2009 2m 18s

BARCELONA, SPAIN—Adding cetuximab to gemcitabine/oxaliplatin (GEMOX) chemotherapy controlled disease among two thirds of patients with advanced biliary cancer in a trial reported at the World Congress on Gastrointestinal Cancer. Éveline Boucher

Metastatic Colorectal Cancer: Capecitabine Equivalent to 5-FU in Irinotecan/Bevacizumab Combos

Sep 28th, 2009 6m 23s

Oncology Times Broadcast News: Metastatic Colorectal Cancer: Capecitabine Equivalent to 5-FU in Irinotecan/Bevacizumab CombosAdding the oral drug capecitabine to a regimen of bevacizumab plus irinotecan was as effective as adding infusion

Stage IV Pancreatic Islet Cell Tumors: Sunitinib Monotherapy Increased Progression Free Survival

Sep 28th, 2009 4m 37s

Oncology Times Broadcast News: Stage IV Pancreatic Islet Cell Tumors: Sunitinib Monotherapy Increased Progression Free SurvivalTreatment of advanced pancreatic islet cell tumors with sunitinib has doubled progression-free survival in patie

Colorectal Cancer: KRAS-Driven Selection Of Molecular Therapy Could Save Millions: Bevacizumab, Cetuximab, Panitumomab, or Combinations?

Sep 28th, 2009 3m 39s

11th Annual Palm Beach Cancer Symposium (April 3-4, 2009 Hollywood, Florida)—Peter Goodwin interviews John Macdonald, Chief Medical Officer of Aptium Oncology in Los Angeles about his data on the relevance of KRAS tumor status to the choice of

Chronic Myeloid Leukemia 'To Become A Very Indolent Disease': Pregnancy Possible, Transplants Avoided—Mission Accomplished?

Sep 28th, 2009 9m 9s

11th Annual Palm Beach Cancer Symposium (April 3-4, 2009 Hollywood, Florida)—Peter Goodwin interviews Hagop Kantarjian MD from the MD Anderson Cancer Center in Houston about his latest findings on treating CML in patients who have the T315I mut

The Smartest Oncologist In The World?

Sep 28th, 2009 6m 12s

11th Annual Palm Beach Cancer Symposium (April 3-4, 2009 Hollywood, Florida)—Peter Goodwin interviews Stanley H Winokur MD from Palm Beach, Florida, about his daily internet quiz that gives oncologists the chance to test their knowledge of canc

Multi-Gene Assays Now Recommended To Refine Chemotherapy Decisions in Breast Cancer

Sep 28th, 2009 7m 15s

11th Annual Palm Beach Cancer Symposium (April 3-4, 2009 Hollywood, Florida)—Peter Goodwin interviews Kathy Albain, Professor of Medicine at Loyola University, Chicago, on her return from the 2009 St Gallen consensus meeting which formulated up

Oropharyngeal Carcinoma: Better Outlook From Human Papilloma Virus-Directed Therapies— Different Patient Characteristics, New Therapeutic Opportunities

Sep 28th, 2009 6m 40s

11th Annual Palm Beach Cancer Symposium (April 3-4, 2009 Hollywood, Florida)—Peter Goodwin interviews Marshall Posner MD from the Dana-Farber Cancer Institute in Boston about the increased prevalence of oropharygeal cancers which are related to

Apr 6th, 2009 12m 9s

Oncology Times Broadcast News with the Audio Journal of OncologyReporting from: 10th European Congress Perspectives in Lung Cancer, Brussels March 6-7, 2009 and Journal of Clinical OncologyCancer Related Fatigue Questionnaires AssessedPad

Bilateral Prophylactic Mastetomy For DCIS

Apr 6th, 2009 10m 46s

Insulin-Like Growth Factor Inhibition In Lung Cancer

Apr 6th, 2009 7m 43s

Oncology Times Broadcast News with the Audio Journal of Oncology - February 2009

Feb 9th, 2009 31m 26s

ONCOLOGY TIMES BROADCAST NEWS WITH THE AUDIO JOURNAL OF ONCOLOGY February 2009Peter Goodwin interviews more speakers from the 50th American Society of Hematology Annual Meeting, San Francisco, December 6-9, 2008 IN THIS EDITION:Greater R

Oncology Times Broadcast News with the Audio Journal of Oncology - January 2009

Jan 7th, 2009 26m 57s

Oncology Times Broadcast NewsJanuary 9th, 2009American Society of Hematology 2008 Meeting ReportReporting From the 2008 Annual Meeting of the American Society of Hematology, San FranciscoThe exciting recent ASH conference reflected the vib

Oncology Times Broadcast News with the Audio Journal of Oncology - November 2008

Nov 11th, 2008 20m 17s

Oncology Times Broadcast News with the Audio Journal of OncologyScientific Editors: George Canellos, Dana-Farber Cancer Institute, Boston Gordon McVie, European Institute of Oncology, MilanPat Price, Christie Hospital, Manchester Gianni B

Rate